MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
93.06
+2.06
+2.26%
Pre Market: 82.38 -10.68 -11.48% 04:01 05/11 EDT
OPEN
91.79
PREV CLOSE
91.00
HIGH
94.86
LOW
91.73
VOLUME
1
TURNOVER
54.97M
52 WEEK HIGH
108.91
52 WEEK LOW
47.25
MARKET CAP
6.06B
P/E (TTM)
22.47
1D
5D
1M
3M
1Y
5Y
1D
LANTHEUS HOLDINGS INC <LNTH.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $103 FROM $98
Reuters · 7h ago
LANTHEUS HOLDINGS INC <LNTH.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $115 FROM $98
Reuters · 7h ago
Lantheus Holdings Balances Near-Term Pressure, Long-Term Growth
TipRanks · 2d ago
Analyst Reiterates Hold on Lantheus as Strong Q1 Fails to Shift Cautious Long‑Term Outlook and PSMA-PET Uncertainty
TipRanks · 2d ago
Lantheus Holdings Is Maintained at Market Outperform by Citizens
Dow Jones · 2d ago
Lantheus Holdings Price Target Raised to $115.00/Share From $85.00 by Citizens
Dow Jones · 2d ago
These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results
Benzinga · 2d ago
Citizens Maintains Market Outperform on Lantheus Holdings, Raises Price Target to $115
Benzinga · 2d ago
More
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. The Company's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The Company's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The Company's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The Company's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.